Navigation Links
Interleukin Genetics Reports Third Quarter 2010 Financial Results
Date:11/11/2010

WALTHAM, Mass., Nov. 11, 2010 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (OTCQB: ILIU) today announced financial and operational results for the third quarter ended September 30, 2010.

Revenue for the three months ended September 30, 2010 was $0.5 million compared to $0.3 million for the same period in the prior year. The increase was primarily attributable to greater genetic test revenue as we experience positive growth.

Research and development expenses were $0.4 million for the three months ended September 30, 2010 compared to $0.9 million for the same period in the prior year. The decrease is primarily attributable to lower clinical trial expenses, compensation and patent portfolio related expenses.

Selling, general and administrative expenses were $1.1 million for the three months ended September 30, 2010, compared to $1.7 million for same period in the prior year. The decrease was primarily attributable to lower product development and advertising costs associated with our Inherent Health™ brand of genetic tests incurred in the rollout of these tests in 2009 and lower administrative consulting and compensation expenses.

The Company reported a net loss from continuing operations of $1.4 million, or $(0.04) per basic and diluted common share, for the third quarter of 2010, compared to a loss from continuing operations of $2.6 million, or $(0.08) per basic and diluted shares for the same period in the prior year. On September 30, 2010, the Company had cash and cash equivalents of $5.2 million.

"We are pleased to show continued revenue driven by our Weight Management genetic test and sales of our new Wellness Select combination product," said Lewis H. Bender, CEO, Interleukin Genetics, Inc. "We are encouraged by the data from clinical programs we have undertaken in the fields of obesity, osteoarthritis and periodontal disease, and look forward to generating results for increased distribution and insurance rei
'/>"/>

SOURCE Interleukin Genetics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Interleukin Genetics Moves Trading of Stock to OTCQB Marketplace
2. Interleukin Genetics, Inc. Announces Conference Call to Discuss Second Quarter 2010 Results
3. Interleukin Genetics, Inc. Announces Conference Call to Discuss First Quarter 2010 Results
4. NYSE Amex Provides Interleukin Genetics, Inc. Extension To Meet Continued Listing Standards
5. Interleukin Genetics to Raise $5.3 Million in Registered Direct Offering
6. Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis
7. Interleukin Genetics, Inc. Announces Positive Results from Clinical Study Evaluating Genetic Tests Impact on Weight Loss
8. Interleukin Genetics Presents Research Linking Vertebral Fractures to Gene Variations in Asian Women With Osteoporosis
9. Interleukin Genetics and Geisinger to Collaborate on Genetic Tests to Predict Weight Loss Success
10. Interleukin Genetics to Present Important New Findings at 2008 World Congress on Osteoarthritis
11. Interleukin Genetics Wins International Award for Outstanding Research Published in the Journal, Nutrition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... Aug. 28, 2014 Levi & Korsinsky announces ... the United States District Court for the District of ... who purchased Galectin Therapeutics Inc. ("Galectin" or the "Company") ... 28, 2014. For more information, click here: ... during the Class Period the Company violated federal securities ...
(Date:8/28/2014)... , August 28, 2014 ... titled, "DNA diagnostics Market (products, applications, techniques, end ... Opportunities, Growth and Forecast, 2013 - 2020," indicates ... $19 billion by 2020 registering a CAGR of ... provide accurate diagnosis and cost effectiveness over alternative ...
(Date:8/28/2014)... Aug. 28, 2014 /PRNewswire-iReach/ -- Gateway Analytical announced ... 9 th Annual Global Pharma Manufacturing Summit ... 8-9 th . The Global Pharma Manufacturing Summit ... small molecule and biologic pharmaceutical manufacturing. The conference ... today,s manufacturers face, such as the increasing pressure ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Galectin Therapeutics Inc. and Its Board of Directors and a Lead Plaintiff Deadline of September 29, 2014 -- GALT 2DNA Diagnostics Market is Expected to Reach $19 Billion by 2020 - Allied Market Research 2DNA Diagnostics Market is Expected to Reach $19 Billion by 2020 - Allied Market Research 3Gateway Analytical to Promote Particulate Identification Services at the 9th Annual Global Pharma Manufacturing Summit 2Gateway Analytical to Promote Particulate Identification Services at the 9th Annual Global Pharma Manufacturing Summit 3
... -- China Health Resource, Inc. (OTCBB: CHRI), today announced results ... the first quarter of 2012. Revenues for ... increase of 234% over revenues of US $10,282,207 for 2010. For ... common share, compared with a net income of $2,707,286, or ...
... Oncos Therapeutics today announced the successful initiation ... adenovirus suggested as a potential new treatment for many types ... safety assessment part of the study. " We ... r thern Europe to start a clinical study with ...
Cached Medicine Technology:China Health Resource Reports on Record Year-End 2011 Results Continuing Strong in 2012 2China Health Resource Reports on Record Year-End 2011 Results Continuing Strong in 2012 3Oncos Therapeutics Initiates Phase I Clinical Study of CGTG-102, an Oncolytic Adenovirus for the Treatment of Solid Tumor Cancers 2
(Date:8/29/2014)... 29, 2014 Top10BestSEOHosting.com today compares ... USA and announces that Bluehost ( http://www.bluehost.com/track/seohosts ), ... hosting companies for webmasters who want to buy ... cloud hosting) at affordable rates. , Bluehost is ... One of its features is that Bluehost provides ...
(Date:8/29/2014)... The Department of Health and Human ... for Food Safety and Applied Nutrition (CFSAN), awarded ... contract and the first two task orders: “FARM ... Enhancement (DME) for FARM VI” to the team ... objectives include:, ,     Upgrade FARM platform ...
(Date:8/29/2014)... Two Kelowna dentists are putting out a ... container filled with classroom materials, clinic supplies and even two ... , “I don’t think words can describe what ... She and her husband, Dr. Jonathan Visscher, both partners at ... of New Reality International’s (NRI) mission to build and raise ...
(Date:8/28/2014)... 2014 When David Gergen, President of ... of Mark Brnovich, was asked to publicly support Mr. ... the Attorney General seat in the State of Arizona, ... support of Cardinal Hall of Fame wide receiver Roy ... and Mark Walczak. Green, Kennard and Walczak are members ...
(Date:8/28/2014)... 2014 Starting on Monday, the ... to accept donations in Bitcoin, in addition to all ... can be found at http://www.curemeso.org/bitcoin . , ... a form of payment, we decided it was important ... chief executive officer, Melinda Kotzian. , Bitcoin is ...
Breaking Medicine News(10 mins):Health News:Top10BestSEOHosting.com: Bluehost, Arvixe, and Hostgator Are the Best Windows Web Hosting from the USA in 2014 2Health News:Team VersaTech and CRGT Win HHS FDA Contract to Support Food Applications Regulatory Management (FARM) System Upgrade 2Health News:Team VersaTech and CRGT Win HHS FDA Contract to Support Food Applications Regulatory Management (FARM) System Upgrade 3Health News:From Canada to Haiti: Kelowna Dentists Raise Funds to Ship Supplies to Self-Sustaining Village for Orphans 2Health News:From Canada to Haiti: Kelowna Dentists Raise Funds to Ship Supplies to Self-Sustaining Village for Orphans 3Health News:Pro Player Health Alliance Back in the Political Arena 2Health News:Pro Player Health Alliance Back in the Political Arena 3Health News:Cancer Research Funding Organization Now Accepts Bitcoin Donations 2
... (HealthDay News) -- Researchers have identified five new genes that ... coronary artery disease -- the most common cause of premature ... study. The international consortium said their discovery could ... treatments for the condition. In conducting the study, published ...
... Disease Alliance (ECDA)1 welcomes the UN High Level Meeting on ... "It is a memorable day in the history of ... gives a strong sense of the burden it represents to ... for all nations in the world2", declared Professor Michel Komajda, ...
... FRIDAY, Sept. 23 (HealthDay News) -- In large and diverse ... stick together, establishing both friendships and romantic relationships with ... people have in who they become close to, the researchers ... prefer to make friends with others who are similar to ...
... 22 (HealthDay News) -- A cardiac rehabilitation program appeared ... second stroke among patients who have suffered mild strokes ... researchers have found. "Overall, following the cardiac rehab ... in their risk profile," study senior investigator Neville Suskin, ...
... calcium-sensitizing drug levosimendan may be effective in improving ... which often accompanies chronic diseases such as chronic ... according to researchers in the Netherlands, who studied ... The drug, which is normally prescribed in patients ...
... , THURSDAY, Sept. 22 (HealthDay News) -- A new ... develop acute leukemia than whites. But if they do become ... know the reason for the disparity, but now that we ... study lead researcher Dr. Manali I. Patel, postdoctoral fellow in ...
Cached Medicine News:Health News:Scientists ID More Genes Linked to Heart Disease 2Health News:Non-communicable diseases at the center of UN discussions 2Health News:People Tend to Choose Friends Just Like Themselves 2Health News:Cardiac Rehab May Cut Risk Factors After Mini-Stroke 2Health News:Heart drug offers possible treatment for patients facing respiratory failure 2Health News:Heart drug offers possible treatment for patients facing respiratory failure 3Health News:Death Rate Higher in Minorities With Acute Leukemia 2
S-ROM acetabular cups provide a variety of geometrical options to help address many anatomical situations and defects....
Interseal acetabular cup system addresses the contemporary issues of the two-piece cementless acetabular component design....
... Alfa acetabular cup system has been designed ... a tri-spiked and cluster hole configurations. The ... minimize micromotion on three primary modes: Tilt, ... design features result in initial and long-term ...
Optimal solution for normal acetabulum....
Medicine Products: